ABOUT MIRUS BIO
For over 25 years, Mirus Bio has pioneered the development of transfection reagents and proprietary technologies for nucleic acid delivery applications. Mirus is establishing the future of science and medicine by developing products that enable product developers within the cell and gene therapy space. As we approach a new era of addressing and conquering life-altering diseases, we will continue to expand our expertise and leadership in transfection to be integral in the future of advanced therapies.
FEATURED PRODUCTS
CONTACT INFORMATION
Mirus Bio
5602 Research Park Blvd, Ste 210
Madison, WI 53719
UNITED STATES
Phone: (608) 4412852
Contact: Nat Connors
FEATURED ARTICLES
-
![GettyImages-1212712327 cell cultures]( "How Can I Increase My Viral Titers And Improve The Percentage Of Full AAVs?")
Explore various strategies to enhance viral titer and increase the percentage of full AAV capsids, like modifications to transfection reagents, cell lines, media, procedures, and more.
-
![Mirus Bio - whats in a product name]( "Choosing The Most Effective Transfection Reagent For Your Needs")
Choosing the right transfection reagent can be confusing. This guide explores product names, their applications, and the importance of testing beyond labeled uses.
-
![Mirus Bio - Transfection]( "What Is Transfection?")
Learna about the process of transfection and why it is crucial for studying gene function and has applications in various fields, including drug development and gene therapy.
-
![Adeno-associated viruses AAV GettyImages-1322096218]( "Rev-Up AAV Genome Production In Upstream Manufacturing")
By increasing recombinant AAV titers, this AAV enhancer can help reduce upstream manufacturing costs and lower the cost per therapeutic dose.
-
![GettyImages-1089913166-lab-science]( "Generation Of Stable CHO Cell Lines For Protein Production")
By following the five steps of a specialized protocol, exceptional yields and stable cell lines can be achieved in CHO cells using antibiotic selection.
-
![Mirus CHOgro]( "Transient Expression Technologies For Antibody Production")
Review studies that showcase the potential of the CHOgro Expression System in early stage drug development, where high titer antibody production in suspension CHO cells is crucial.
-
![CHOgro® High Yield Expression System]( "High Yield Protein Production System For Suspension CHO Cells")
Reduced the risk of contamination caused by repeated handling of the culture during transient protein production in suspension CHO cells.
-
![VirusGEN and RevIT]( "Universal AAV Enhancer For Better Titers, Quality, And Lower Costs")
AAV therapies require high quality and high titers of viral genomes per dosage, prompting the need for a more efficient AAV manufacturing method to reduce overall costs.
VIDEOS
-
![GettyImages-1439447135-stem-cell-dna]( "A Novel Transfection System For Cell And Gene Therapy Applications")
An innovative transfection system addresses common production challenges by offering higher AAV titers, improved percent-full AAV capsids, and a straightforward workflow for AAV production platforms.
-
![Mirus - AAV platform webinar]( "Engineering An AAV Platform For Superior Titer And Capsid Integrity")
Learn how to optimize AAV manufacturing with a transfection reagent and enhancer platform that boosts titers and percent full capsids by 2- to 10-fold, featuring insights from real-world case studies.
-
![Mirus Bio Bio-Expo Live 2024 Upstream Bioprocessing]( "Mirus Bio Bio-Expo Live 2024: Upstream Bioprocessing")
Explore a proprietary economic model which quantitates the impact of upstream process optimization with varying transfection technologies using real world case studies.
-
![GettyImages-1214763114 Medical Research Scientist Working In Laboratory]( "TransIT-VirusGEN Transfection For AAV And Lentivirus Production")
Explore how the development of transfection reagents and proprietary technologies for nucleic acid delivery applications is helping product developers in the cell & gene therapy space.
